BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17588477)

  • 21. Human purified CD8+ T cells: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells.
    Al-Shanti N; Aldahoudi Z
    Immunol Invest; 2007; 36(1):85-104. PubMed ID: 17190652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
    Paine A; Oelke M; Blasczyk R; Eiz-Vesper B
    Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
    Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
    Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
    Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
    Oelke M; Maus MV; Didiano D; June CH; Mackensen A; Schneck JP
    Nat Med; 2003 May; 9(5):619-24. PubMed ID: 12704385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy.
    Rasmussen AM; Borelli G; Hoel HJ; Lislerud K; Gaudernack G; Kvalheim G; Aarvak T
    J Immunol Methods; 2010 Apr; 355(1-2):52-60. PubMed ID: 20171968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Risso M; Tripodi G; Manca F
    Transfusion; 2006 Dec; 46(12):2053-62. PubMed ID: 17176316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
    Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
    Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
    Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
    Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [T lymphocytes with chimeric receptor induce carcinoembryonic antigen-positive specific gastric carcinoma cells apoptosis].
    Xu HY; Xu L; Gao JH; Li KZ; Dou KF
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1053-7. PubMed ID: 17672971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
    Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
    J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
    Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
    J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
    Daudt L; Maccario R; Locatelli F; Turin I; Silla L; Montini E; Percivalle E; Giugliani R; Avanzini MA; Moretta A; Montagna D
    J Immunother; 2008 May; 31(4):385-93. PubMed ID: 18391757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.
    Wang X; Popplewell LL; Wagner JR; Naranjo A; Blanchard MS; Mott MR; Norris AP; Wong CW; Urak RZ; Chang WC; Khaled SK; Siddiqi T; Budde LE; Xu J; Chang B; Gidwaney N; Thomas SH; Cooper LJ; Riddell SR; Brown CE; Jensen MC; Forman SJ
    Blood; 2016 Jun; 127(24):2980-90. PubMed ID: 27118452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.
    Perret R; Ronchese F
    Eur J Immunol; 2008 Oct; 38(10):2886-95. PubMed ID: 18825745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.
    Salot S; Laplace C; Saïagh S; Bercegeay S; Tenaud I; Cassidanius A; Romagne F; Dreno B; Tiollier J
    J Immunol Methods; 2007 Sep; 326(1-2):63-75. PubMed ID: 17716681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.
    Marin V; Kakuda H; Dander E; Imai C; Campana D; Biondi A; D'Amico G
    Exp Hematol; 2007 Sep; 35(9):1388-97. PubMed ID: 17656004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive selection and expansion of cytomegalovirus-specific CD4 and CD8 T cells in sealed systems: potential applications for adoptive cellular immunoreconstitution.
    Li Pira G; Ivaldi F; Tripodi G; Martinengo M; Manca F
    J Immunother; 2008 Oct; 31(8):762-70. PubMed ID: 18779743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
    J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.